CVE-2024-52809

Cross-site Scripting vulnerability with prototype pollution in vue-i18n

Description

vue-i18n is an internationalization plugin for Vue.js. In affected versions vue-i18n can be passed locale messages to `createI18n` or `useI18n`. When locale message ASTs are generated in development mode there is a possibility of Cross-site Scripting attack. This issue has been addressed in versions 9.14.2, and 10.0.5. Users are advised to upgrade. There are no known workarounds for this vulnerability.

Category

5.3
CVSS
Severity: Medium
CVSS 4.0 •
EPSS 0.17%
Affected: intlify vue-i18n
Published at:
Updated at:

References

Link Tags
https://github.com/intlify/vue-i18n/security/advisories/GHSA-9r9m-ffp6-9x4v
https://github.com/intlify/vue-i18n/commit/72f0d323006fc7363b18cab62d4522dadd874411
https://github.com/intlify/vue-i18n/commit/9f20909ef8c9232a1072d7818e12ed6d6451024d

Frequently Asked Questions

What is the severity of CVE-2024-52809?
CVE-2024-52809 has been scored as a medium severity vulnerability.
How to fix CVE-2024-52809?
To fix CVE-2024-52809, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-52809 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-52809 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-52809?
CVE-2024-52809 affects intlify vue-i18n.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.